Pathway-based approach reveals differential sensitivity of glioblastoma to E2F1 inhibition

Alvaro G. Alvarado(University of California, Los Angeles), Harley I. Kornblum(Neurobehavioral Systems)
bioRxiv (Cold Spring Harbor Laboratory)
June 19, 2021
Cited by 0


Related Papers